These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1964750)
1. The platelet count in carcinoma of the lung and colon. Costantini V; Zacharski LR; Moritz TE; Edwards RL Thromb Haemost; 1990 Dec; 64(4):501-5. PubMed ID: 1964750 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Wojtukiewicz MZ; Zacharski LR; Moritz TE; Hur K; Edwards RL; Rickles FR Blood Coagul Fibrinolysis; 1992 Aug; 3(4):429-37. PubMed ID: 1330024 [TBL] [Abstract][Full Text] [Related]
3. Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia. Werynska B; Ramlau R; Podolak-Dawidziak M; Jankowska R; Prajs I; Usnarska-Zubkiewicz L; Kuliczkowski K Neoplasma; 2003; 50(6):447-51. PubMed ID: 14689068 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Pedersen LM; Milman N Oncol Rep; 2003; 10(1):213-6. PubMed ID: 12469171 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer. Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952 [TBL] [Abstract][Full Text] [Related]
6. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
8. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis. Boher JM; Pujol JL; Grenier J; Daurès JP Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885 [TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery. Faulkner LB; Lindsley KL; Kher U; Heller G; Black P; Finlay JL Bone Marrow Transplant; 1996 Mar; 17(3):389-94. PubMed ID: 8704692 [TBL] [Abstract][Full Text] [Related]
10. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):613-5. PubMed ID: 18502783 [TBL] [Abstract][Full Text] [Related]
12. High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer. Wilson C; Pickering D; Stewart S; Vallis K; Kalofonos H; Cross A; Snook D; Goldman JM; McKenzie CG; Epenetos AA In Vivo; 1988; 2(5):331-4. PubMed ID: 2856521 [TBL] [Abstract][Full Text] [Related]
13. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome. Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
15. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation. Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Naumnik W; Izycki T; Swidzińska E; Ossolińiska M; Chyczewska E Oncol Res; 2007; 16(9):445-51. PubMed ID: 18074680 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of tumor markers in the management of small cell lung cancer]. Ariyoshi Y Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):959-65. PubMed ID: 2839115 [TBL] [Abstract][Full Text] [Related]
19. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Suppiah R; Shaheen PE; Elson P; Misbah SA; Wood L; Motzer RJ; Negrier S; Andresen SW; Bukowski RM Cancer; 2006 Oct; 107(8):1793-800. PubMed ID: 16983701 [TBL] [Abstract][Full Text] [Related]
20. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA. Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]